FAKTOR-OPTIONSSCHEIN - DEXCOM Share Price

DE000MG18DT3

Market Closed - Börse Stuttgart 01:14:09 18/05/2024 am IST
9.24 ^EUR	+6.82%

Current month	-34.84%
1 month	-6.48%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DEXCOM, INC.

Latest news about DEXCOM, INC.

DexCom : Human Rights Statement	09/05	PU
Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology	30/04	CI
Wall Street: the worst week of 2024 is followed by the best	27/04	CF
Morgan Stanley Adjusts DexCom's Price Target to $132 From $122	26/04	MT

More news

Quotes 5-day view

Date	Price	Change
17/24/17	9.24	+6.82%
16/24/16	8.65	-34.37%
15/24/15	13.18	-11.07%
14/24/14	14.82	+19.13%
13/24/13	12.44	+20.08%

Delayed Quote Börse Stuttgart

Last update May 18, 2024 at 01:14 am IST

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	DEXCOM, INC.
Issuer	Morgan Stanley
WKN	MG18DT
ISIN	DE000MG18DT3
Date issued	28/03/2024
Strike	148.4 $
Maturity	Unlimited
Parity	1.74 : 1
Emission price	10 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	15.93 €
Lowest since issue	8.21 €
Spread	0.1 €
Spread %	1.09%

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

More about the company

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DexCom, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

131.4 USD

Average target price

151.2 USD

Spread / Average Target

+15.12%

Consensus